[1] |
吕震.胃肠手术中患者给予快速康复治疗后的疗效分析[J/CD].中华普外科手术学杂志(电子版),2017,11(4):341-344.
|
[2] |
王权,夏明杰.加速康复外科措施对进展期胃癌围手术期C-反应蛋白及内脏蛋白的影响[J].临床与病理杂志,2015, 35(s1):30-30.
|
[3] |
张玉江,周军,阿合提别克,等.快速康复外科理念在新辅助化疗联合腹腔镜下胃癌D2根治术治疗进展期胃癌中的应用[J].中华实用诊断与治疗杂志,2018,32(5):467-470.
|
[4] |
聂爱清,马雅娟,孙胡春,等.循证护理对进展期胃癌根治术患者治疗效果及生活质量的影响[J].中国肿瘤临床与康复,2018,25(5),599-602.
|
[5] |
Wang X, Zhao L, Liu H, et al. A phase II study of a modified FOLFOX6 regimen as neoadjuvant chemotherapy for locally advanced gastric cancer[J]. British Journal of Cancer, 2016, 114(12):1326-1333.
|
[6] |
Inadomi K,Kusaba H,Matsushita Y,et al.Efficacy and Safety Analysis of Oxaliplatin-based Chemotherapy for Advanced Gastric Cancer[J].Anticancer Research, 2017, 37(5):2663-2671.
|
[7] |
吴金东,高志斌,江晓晖,等.ERAS外科理念在腹腔镜辅助远端胃癌根治术中的临床应用研究[J].实用癌症杂志,2017, 32(3):421-424.
|
[8] |
Viapiana P, Costa WL, Heber SDCR, et al. P-094Early and long-term outcomes of gastric cancer patients treated with perioperative chemotherapy and radical surgery in a single cancer center[J]. Annals of Oncology, 2016, 27(suppl 2):ii28.
|
[9] |
裴哲,周博,金灿辉,等.快速康复外科理念应用于老年进展期胃癌患者围术期的回顾性对照研究[J].医学研究杂志,2017,46(7):129-133.
|
[10] |
Bando H, Doi T, Muro K, et al. The final results of a multicenter phase II study of TAS-102 monotherapy in patients with pre-treated advanced gastric cancer (EPOC1201)[J]. European Journal of Cancer, 2016, 62(suppl 6):46-53.
|
[11] |
叶松.ERAS对青中年胃癌手术治疗近远期疗效的影响分析[J].实用癌症杂志,2017, 32(9):1511-1514.
|
[12] |
Zhu XR, Zhu ML, Wang Q, et al. A case report of targeted therapy with apatinib in a patient with advanced gastric cancer and high serum level of alpha-fetoprotein[J]. Medicine(Baltimore), 2016, 95(37):e4610.
|
[13] |
葛晓明,孙晓光,杨剑,等.腹腔镜胃癌根治术治疗进展期胃癌的临床效果分析[J].实用临床医药杂志,2017, 21(7):64-66,84.
|
[14] |
Lin JX,Huang C,Zheng C,et al.Morbidity and mortality of laparoscopic gastrectomy versus open gastrectomy for advanced gastric cancer: A single center, prospective, randomized trial[J]. Journal of Clinical Oncology, 2016,34(Suppl 4):55.
|
[15] |
王琛. 行为及心理干预对进展期胃癌行腹腔镜D2根治术患者情绪及生活质量的影响[J]. 海南医学,2017, 28(16):2747-2750.
|
[16] |
Yang W, Hu R, Li GC, et al. Survival outcomes and patterns of failure after D2 dissection and adjuvant chemoradiotherapy for locally advanced gastric cancer: a retrospective study[J]. British Journal of Radiology, 2018, 91(1089):20170594.
|
[17] |
M??Ller BG, Garcia C, Sola JA, et al.Perioperative chemotherapy in locally advanced gastric cancer in Chile: From evidence to daily practice[J].Journal of Clinical Oncology, 2016, 34(4):92.
|
[18] |
Jung YJ, Seo HS, Lee HH, et al. Splenic Infarction as a Delayed Febrile Complication Following Radical Gastrectomy for Gastric Cancer Patients: Computed Tomography-Based Analysis[J]. World Journal of Surgery, 2018, 42(6):1826-1832.
|
[19] |
Kang SH, Lee Y, Min SH, et al. Multimodal Enhanced Recovery After Surgery (ERAS) Program is the Optimal Perioperative Care in Patients Undergoing Totally Laparoscopic Distal Gastrectomy for Gastric Cancer: A Prospective, Randomized, Clinical Trial[J]. Annals of Surgical Oncology, 2018,25(11):3231-3238.
|